Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
American Stock Exchange will continue Nephros's listing
December 24th, 2006
Nephros, Inc. (NEP) announced that the staff of the American Stock Exchange (AMEX) has reviewed the company's plan of compliance to meet the AMEX's continued listing standards and will continue the company's listing while the company seeks to regain compliance with the continued listing standards during the period ending January 17, 2008. During the plan period, the company must continue to provide the AMEX staff with updates regarding initiatives set forth in its plan of compliance. The company will be subject to periodic review by the AMEX staff during the plan period. If the company is not in compliance with the continued listing standards at January 17, 2008 or the...
Source: Medical Devices & Surgical Technology Week (2006-12-24)
|
